NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,116 | -80.2% | 28,738 | -80.9% | 0.00% | -77.8% |
| Q2 2023 | $86,369 | -18.2% | 150,154 | 0.0% | 0.01% | -10.0% |
| Q1 2023 | $105,543 | -81.0% | 150,154 | -39.0% | 0.01% | -84.6% |
| Q4 2022 | $556,236 | -44.3% | 246,122 | -21.1% | 0.06% | -16.7% |
| Q3 2022 | $999,000 | -9.5% | 312,107 | +7.4% | 0.08% | -14.3% |
| Q2 2022 | $1,104,000 | +102.2% | 290,489 | +186.9% | 0.09% | +97.8% |
| Q1 2022 | $546,000 | +23.0% | 101,237 | +208.3% | 0.05% | +17.9% |
| Q4 2021 | $444,000 | -34.5% | 32,835 | -13.0% | 0.04% | -51.9% |
| Q3 2021 | $678,000 | +289.7% | 37,759 | +273.3% | 0.08% | +200.0% |
| Q2 2021 | $174,000 | -56.7% | 10,114 | -57.2% | 0.03% | -78.6% |
| Q4 2020 | $402,000 | – | 23,644 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |